ft819,aldesleukin
fate therapeutics,prometheus,novartis,clinigen
['bet', '2000', 'dlbcl']
#ash22 outcomes of dlbcl in patients achieving cr after r-ice: refractory and early relapse &lt;12 mo patients achieving cr after r-ice may achieve lt disease control with asct (1/3) 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??